Condition category
Injury, Occupational Diseases, Poisoning
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Based on government reports, approximately 4.9 days per employee are lost to sickness per year, costing the economy approximately 9 billion a year on sick pay which averages at £760 per employee. There is strong research evidence to support the use of mindfulness-based interventions in a clinical a setting to reduce stress, anxiety and depression. This study will investigate if those benefits are transferable into the workplace and if mindfulness-based training would be a cost effective measure to reduce workplace sickness and improve quality of life. Mindfulness in the workplace is a fast growing area of interest but currently there is little robust research evidence to evaluate the impact. This study will evaluate the impact over a minimum one year period. Participants will be offered an 8 week mindfulness-based programme adapted for workplace delivery. The programme will be provided by trainers who have been trained by the Centre for Mindfulness Research and Practice (CMRP), Bangor University (UK).

Who can participate?
Staff members in NHS England (up to 4 sites).

What does the study involve?
Everyone who takes part in the study will be offered mindfulness training in the workplace. The training is based on the popular 8 week mindfulness programme with adaptations for workplace delivery and an additional week for orientation. As part of the research into this training we will electronically issue questionnaires to two groups of people at a time: one group will receive the mindfulness training (the training group) and one will not (the control group). The questionnaires will be completed immediately before the first mindfulness training class (week 1) and immediately after the last class (week 9) of each programme. Then, after the training groups have received the training the control groups will be offered the training. Follow up periods will be immediately after the training, 3 months and 6 months post training. If possible there will also be a 12 month follow up. This process will be simultaneously replicated in up to 4 separate geographical sites across England NHS.

What are the possible benefits and risks of participating?
Participants may find it interesting and rewarding to participate in a research study. When participating in the mindfulness training participants may experience positive wellbeing outcomes such as perceived reduced anxiety, stress and depression levels (reported in many clinical studies). There is no identified risk in participating in this research. Information we get from this study will help us understand more about how mindfulness in the workplace can help people deal with everyday stress and difficulties and will be used to advise and inform further research and possible implementation of the intervention. This means that by taking part participants will be helping others in the future. Once the study has been completed we will provide everyone who took part with information about the findings.

Where is the study run from?
The study will be run from the coordinating centre at Bangor University with up to four recruiting centres across NHS England (Manchester, Liverpool, Leeds and London).

When is study starting and how long is it expected to run for?
The study is expected to start in January 2014 for a period of 12 months.

Who is funding the study?
The study is part funded by Bangor University and by NHS England (UK).

Who is the main contact?
Ms Sharon Grace Hadley, Business Manager

Trial website

Contact information



Primary contact

Ms Sharon Grace Hadley


Contact details

Centre for Mindfulness Research and Practice (CMRP)
Dean Street
Bangor University
LL57 1UT
United Kingdom
+44 1248 382498

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Longitudinal evaluation of cost effectiveness and wellbeing related variables of mindfulness training in the workplace



Study hypothesis

We hypothesise that:
1. Employees who receive mindfulness training will be less stressed / anxious / depressed than employees who do not have the training. We believe this will result in reduced sickness rates.
2. Employees who receive mindfulness training will be benefit from an improved quality of life. We hypothesise that these feelings of quality of life improvement will result in elevated state of mood and reduced levels of perceived stress.
3. We hypothesise that a reduction in employee perceived stress, improvement in quality of life and changes in mood will result in a different state of organisational culture.
4. We also hypothesise that from the impact of improved wellbeing and increased quality of life and perceived stress will come a cost benefit.

Ethics approval

Bangor University School of Psychology Ethics Approval, 2013-9304

Study design

Phased blind multi-centre randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type

Quality of life

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet


Emotional Wellbeing


Participants will be randomised to either mindfulness training (T) or control groups (C). The intervention is a 8 week taught mindfulness programme which will be measured using mainly a quantitative research method of self report questionnaires which will be electronically emailed to participants. There will be some qualitative interviews after the training has been completed to explore how practical it was for employees to experience this training in the workplace.

Intervention type



Not Applicable

Drug names

Primary outcome measure

1. Cost Effectiveness

Self-assessed levels of:
1. Stress
2. Mindfulness
3. Quality of life
4. Mood States
5. Memory

They are measured at baseline, immediately after the intervention, 3 months post intervention, 6 months post intervention and 12 months post intervention.

Secondary outcome measures

If participants are in a leadership role: Leadership style questionnaires will be used to measure the impact on leadership style

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. The participant must be an employee within the workplace
2. The participant must be in work and interested in mindfulness
3. The participant must be able to give informed consent
4. The participant must be able to attend a minimum of 6 of the 8 sessions

Participant type


Age group




Target number of participants


Participant exclusion criteria

1. Participants will be excluded if they have recently experienced trauma, are in deep depressive state or experiencing any mental health issues that would make the mindfulness training difficult
2. Participants will be excluded if they are unable to speak English

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Centre for Mindfulness Research and Practice (CMRP)
Brigantia Building School of Psychology Bangor University Bangor Gwynedd
LL57 1UT
United Kingdom

Sponsor information


Bangor University (UK)

Sponsor details

Dean Street
LL57 1UT
United Kingdom

Sponsor type




Funder type


Funder name

Bangor University (UK)

Alternative name(s)

Funding Body Type

private sector organisation

Funding Body Subtype

Universities (academic only)


United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration.

Intention to publish date

Participant level data

Not provided at time of registration

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

03/06/2019: The following changes were made to the trial record: 1. Contact details updated. 2. The overall trial end date was changed from 15/01/2015 to 31/12/2019. 31/05/2019: Internal review. 26/01/2017: No publications found in PubMed, verifying study status with principal investigator.